Literature DB >> 15994809

Compartmentalization of hepatitis C virus quasispecies in blood mononuclear cells of patients with mixed cryoglobulinemic syndrome.

Gianguglielmo Zehender1, Chiara De Maddalena, Flavia Bernini, Erika Ebranati, Giuseppe Monti, Piero Pioltelli, Massimo Galli.   

Abstract

The aim of this study was to investigate the quasispecies heterogeneity of hepatitis C virus (HCV) in the plasma, cryoprecipitate, and peripheral lymphocytes of chronically infected HCV patients with mixed cryoglobulinemia (MC). We studied 360 clones from 10 HCV-positive patients with MC and 8 age-, gender- and HCV genotype-matched subjects with chronic HCV infection but without MC. A partial nucleotide sequence encompassing the E1/E2 region, including hypervariable region 1 (HVR1), was amplified and cloned from plasma, cryoprecipitates, and peripheral blood mononuclear cells (PBMC), and the genetic diversity and complexity and synonymous and nonsynonymous substitution rates were determined. Heterogeneous selection pressure at codon sites was evaluated. Compartmentalization was estimated by phylogenetic and phenetic (Mantel's test) approaches. The patients with MC had 3.3 times lower nonsynonymous substitution rates (1.7 versus 5.7 substitutions/100 sites). Among the subjects with HCV genotype 1, the MC patients had significantly less complexity than the controls, whereas the diversity and complexity were similar in the genotype 2 patients and controls. Site-specific selection analysis confirmed the low frequency of MC patients showing positive selection. There was a significant correlation between positive selection and the infecting HCV genotype. The quasispecies were less heterogeneous in PBMC than in plasma. Significant compartmentalization of HCV quasispecies was observed in the PBMC of four of nine subjects (three with MC) and seven of nine cryoprecipitates. In one subject with MC, we detected a 5-amino-acid insertion at codons 385 to 389 of HVR1. Our results suggest reduced quasispecies heterogeneity in MC patients that is related to a low selection pressure which is probably due to an impaired immune response, the HCV genotype, and/or the duration of the infection. The frequent HCV quasispecies compartmentalization in patients' PBMC suggests a possible pathogenetic significance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994809      PMCID: PMC1168762          DOI: 10.1128/JVI.79.14.9145-9156.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Codon-substitution models for heterogeneous selection pressure at amino acid sites.

Authors:  Z Yang; R Nielsen; N Goldman; A M Pedersen
Journal:  Genetics       Date:  2000-05       Impact factor: 4.562

2.  Genetic characterization of hypervariable region 1 in patients chronically infected with hepatitis C virus genotype 2.

Authors:  X Fan; A M Di Bisceglie
Journal:  J Med Virol       Date:  2001-07       Impact factor: 2.327

3.  Evolutionary rate and genetic drift of hepatitis C virus are not correlated with the host immune response: studies of infected donor-recipient clusters.

Authors:  J P Allain; Y Dong; A M Vandamme; V Moulton; M Salemi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 4.  Clinical significance of hepatitis C virus genotypes and quasispecies.

Authors:  P Farci; R H Purcell
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

5.  Cryoglobulinemia in Japanese patients with chronic hepatitis C virus infection: host genetic and virological study.

Authors:  A Nagasaka; T Takahashi; T Sasaki; K Takimoto; K Miyashita; M Nakamura; O Wakahama; S Nishikawa; A Higuchi
Journal:  J Med Virol       Date:  2001-09       Impact factor: 2.327

Review 6.  Hepatitis C viral quasispecies.

Authors:  J Gómez; M Martell; J Quer; B Cabot; J I Esteban
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

7.  Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.

Authors:  A Tagger; F Donato; M L Ribero; R Chiesa; G Portera; U Gelatti; A Albertini; M Fasola; P Boffetta; G Nardi
Journal:  Int J Cancer       Date:  1999-05-31       Impact factor: 7.396

8.  A 385 insertion in the hypervariable region 1 of hepatitis C virus E2 envelope protein is found in some patients with mixed cryoglobulinemia type 2.

Authors:  M Gerotto; F Dal Pero; S Loffreda; F B Bianchi; A Alberti; M Lenzi
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

9.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Authors:  P Farci; A Shimoda; A Coiana; G Diaz; G Peddis; J C Melpolder; A Strazzera; D Y Chien; S J Munoz; A Balestrieri; R H Purcell; H J Alter
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

10.  Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets.

Authors:  A M Roque Afonso; J Jiang; F Penin; C Tareau; D Samuel; M A Petit; H Bismuth; E Dussaix; C Féray
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

View more
  18 in total

1.  Hepatitis C hypervariable region 1: association of reduced selection pressure in african americans with treatment failure.

Authors:  Vicki M Park; Barbara C Mason; Julia Krushkal; Rongling Li; Caroline Riely; Jaquelyn Fleckenstein
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

Review 2.  Mechanisms of HCV survival in the host.

Authors:  Ella H Sklan; Prista Charuworn; Philip S Pang; Jeffrey S Glenn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

3.  Antibody to E1 peptide of hepatitis C virus genotype 4 inhibits virus binding and entry to HepG2 cells in vitro.

Authors:  Mostafa K El-Awady; Ashraf A Tabll; Khaled Atef; Samar S Yousef; Moataza H Omran; Yasmin El-Abd; Noha G Bader-Eldin; Ahmad M Salem; Samir F Zohny; Wael T El-Garf
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

4.  Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue.

Authors:  Djamila Harouaka; Ronald E Engle; Kurt Wollenberg; Giacomo Diaz; Ashley B Tice; Fausto Zamboni; Sugantha Govindarajan; Harvey Alter; David E Kleiner; Patrizia Farci
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

5.  Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV.

Authors:  Jason T Blackard; Gang Ma; Satarupa Sengupta; Christina M Martin; Eleanor A Powell; M Tarek Shata; Kenneth E Sherman
Journal:  J Med Virol       Date:  2014-04-30       Impact factor: 2.327

6.  Genetic diversity of hepatitis C virus predicts recurrent disease after liver transplantation.

Authors:  Hui Li; Daniel G Sullivan; Nathan Feuerborn; Susan McArdle; Kirubeal Bekele; Sampa Pal; Matthew Yeh; Robert L Carithers; James D Perkins; David R Gretch
Journal:  Virology       Date:  2010-04-18       Impact factor: 3.616

7.  Analysis of hepatitis C virus hypervariable region 1 sequence from cryoglobulinemic patients and associated controls.

Authors:  Gabriella Bianchettin; Claudia Bonaccini; Romina Oliva; Anna Tramontano; Agostino Cividini; Milvia Casato; Giampaolo Merlini; Enrico Silini; Mario U Mondelli
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

8.  Compartmentalization of hepatitis B virus: Looking beyond the liver.

Authors:  Sibnarayan Datta
Journal:  World J Hepatol       Date:  2015-09-18

9.  Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.

Authors:  Jason T Blackard; Gang Ma; Jeffrey A Welge; Christina M Martin; Kenneth E Sherman; Lynn E Taylor; Kenneth H Mayer; Denise J Jamieson
Journal:  J Med Virol       Date:  2012-02       Impact factor: 2.327

Review 10.  Role of miR-122 and lipid metabolism in HCV infection.

Authors:  Takasuke Fukuhara; Yoshiharu Matsuura
Journal:  J Gastroenterol       Date:  2012-09-11       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.